Serum Institute of India
Serum Institute of India is a manufacturer of immunobiological drugs including vaccines in India.[1][2] It was founded by Cyrus Poonawalla in 1966.[3] The company is a subsidiary of the holding company Poonawalla Investment & Industries, founded in 1966 and controlled by billionaire Cyrus Poonawalla.
Founder | Cyrus S. Poonawalla |
---|---|
Headquarters | Pune, India |
Key people | Adar Poonawalla (President) |
Revenue | |
Website | www |
The company is the world's largest vaccine producer by number of doses produced.[4] The company produces around 1.3 billion doses of vaccines each year. In 2020, the pharmaceutical company AstraZeneca; in collaboration with Oxford University, is contracting for 1 billion doses of the Institute's capacity for it's COVID-19 vaccine. [5] The products developed include tuberculosis vaccine Tubervac (BCG), Poliovac for poliomyelitis, and other vaccinations for the childhood vaccination schedule.[6] [7] [8]
As of 2009, the institute was developing an intranasal swine flu vaccine.[9] In 2016, with support from US-based Mass Biologics of the University of Massachusetts Medical School, it invented a fast-acting anti-rabies agent, Rabies Human Monoclonal Antibody (RMAb), also known as Rabishield.[10]
References
- "Serum Institute of India Pvt. Ltd.: Private Company Information". bloomberg.com. Retrieved 30 September 2018.
- "SERUM INSTITUTE OF INDIA PRIVATE LIMITED - Company, directors and contact details". zaubacorp.com. Retrieved 30 September 2018.
- "About Us". Serum Institute of India. Retrieved 8 December 2016.
- "Cyrus Poonawalla on Forbes Lists". Forbes. Retrieved 24 March 2015.
- "AstraZeneca & Serum Institute of India sign licensing deal for 1 billion doses of Oxford vaccine". The Economic Times. Retrieved 15 June 2020.
- "Serum Institute Tubervac (BCG)". Serum Institute of India. Retrieved 15 June 2020.
- "Serum Institute Poliovac". Serum Institute of India. Retrieved 15 June 2020.
- "Vaccination Schedule". Vaccination as per the National Immunization schedule by Government of India. Retrieved 15 June 2020.
- "India developing indigenous swine flu vaccine". The Times of India. Retrieved 1 February 2015.
- "Fast-acting anti-rabies drug set for India launch - Times of India". The Times of India. Retrieved 12 June 2016.